{
  "meta": {
    "title": "Communicable_Disease_Vector-Borne_Disease_Part2",
    "url": "https://brainandscalpel.vercel.app/communicable-disease-vector-borne-disease-part2-d01fd1ff.html",
    "scrapedAt": "2025-11-30T11:18:29.953Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2 days</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">4-6 days</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">8-10 days</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">12-14 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The extrinsic incubation period of the dengue virus is -</span></p>",
      "unique_key": "DT1231414",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231414,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The extrinsic incubation period (EIP) of dengue virus is the time taken for the virus to develop inside the mosquito vector after ingesting blood from an infected human until it becomes capable of transmitting the virus. In dengue, the EIP is usually <strong>8-10 days</strong> under optimal environmental conditions. During this time, the virus multiplies in the mosquito's midgut and spreads to the salivary glands, enabling transmission during subsequent bites.</p>\r\n<ul>\r\n<li><strong>Definition:</strong> The Interval between the ingestion of the virus by the mosquito and its ability to transmit it.</li>\r\n<li><strong>Duration:</strong> Typically 8-10 days in Aedes aegypti under suitable temperature and humidity.</li>\r\n<li><strong>Environmental effect:</strong> Higher ambient temperature shortens the incubation period, increasing transmission potential.</li>\r\n<li><strong>Public health relevance:</strong> Reducing mosquito longevity below the EIP duration interrupts transmission.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>1-2 days (Option A):</strong> Too short for dengue virus replication and dissemination within the mosquito.</p>\r\n<p><strong>4-6 days (Option B):</strong> Shorter than typical; the virus usually needs more time to complete its developmental cycle in the vector.</p>\r\n<p><strong>12-14 days (Option D):</strong> Longer than the usual range; though possible under suboptimal conditions, the standard period is shorter.</p>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">9-11 pm</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">2-5 am</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">10 pm-2 am</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">6-8 pm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Maximum density of microfilariae in blood is reported to occur between:</span></p>",
      "unique_key": "DT1231415",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231415,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The density of microfilariae in peripheral blood follows a circadian rhythm, showing marked nocturnal periodicity. This periodicity coincides with the biting habits of the night-feeding mosquito vectors, thus enhancing the chances of transmission.</p>\r\n<ul>\r\n<li><strong>10 pm-2 am</strong> is the peak period when microfilariae appear in maximum numbers in peripheral blood, making this the optimal time for night blood surveys.</li>\r\n<li>This timing is utilized in epidemiological surveys and diagnosis to maximize detection rates.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>9-11 pm (Option A):</strong> Microfilarial count starts rising during this period but does not yet reach the peak.</p>\r\n<p><strong>2-5 am (Option B):</strong> Counts remain elevated but begin to decline after the peak period.</p>\r\n<p><strong>6-8 pm (Option D):</strong> Represents an early evening period when counts are still low before the nocturnal rise begins.</p>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Blockage of lymphatics</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">First appearance of detectable microfilaria</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Development of lymphoedema</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Maturation into adult worm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Prepatent period in lymphatic filariasis is the time interval between inoculation of infective larvae and -</span></p>",
      "unique_key": "DT1231416",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231416,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The prepatent period in lymphatic filariasis refers to the duration between the entry of infective larvae (L3 stage) into the human body via a mosquito bite and the first appearance of detectable microfilariae in the peripheral blood. This is the point at which the infection becomes demonstrable through blood examination.</p>\r\n<ul>\r\n<li><strong>Definition:</strong> The prepatent period ends when microfilariae, produced by adult worms in the lymphatics, are first detectable in the blood.</li>\r\n<li><strong>Duration:</strong> Typically ranges from 8-16 months, though it may vary depending on factors such as species and host immunity.</li>\r\n<li><strong>Process:</strong>\r\n<ul>\r\n<li>Infective larvae (L3) penetrate the skin at the mosquito bite site.</li>\r\n<li>They migrate to lymphatic vessels and develop into adult worms.</li>\r\n<li>After mating, the female worms release microfilariae, which circulate in the blood.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250925bfd5860c-fc33-4c26-a2e9-3c548c623195.png\"></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Blockage of lymphatics (Option A):</strong> This is a late, chronic manifestation of lymphatic filariasis due to fibrosis and obstruction from adult worms in lymphatic vessels. It leads to lymphoedema, hydrocele, and elephantiasis, but it does not define the prepatent period, which ends when microfilariae first become detectable in blood.</p>\r\n<p><strong>Development of lymphoedema (Option C):</strong> Lymphoedema results from chronic lymphatic obstruction and is a late sequela of the disease, not an event marking the end of the prepatent period.</p>\r\n<p><strong>Maturation into adult worm (Option D):</strong> Although maturation occurs during the prepatent period, this stage is not the defining endpoint. The prepatent period specifically ends with the first appearance of detectable microfilariae in blood.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Thick film</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Thin film</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Membrane filter concentration</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">DEC provocation test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most sensitive method to detect low-density microfilaremia in blood is-</span></p>",
      "unique_key": "DT1231417",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231417,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p><strong>Membrane filter concentration</strong> detects even <strong>very low microfilarial densities</strong> by filtering a <strong>large volume of blood</strong> and concentrating organisms on a membrane for microscopy, making it the most <strong>sensitive</strong> option.</p>\r\n<ul>\r\n<li><strong>Principle:</strong> Concentrates microfilariae by passing blood through a <strong>membrane filter</strong> so trapped larvae can be <strong>counted/seen</strong> under the microscope.</li>\r\n<li><strong>Why most sensitive:</strong> Handles <strong>larger blood volumes</strong> than routine smears, so it picks up <strong>low-density microfilaremia</strong> that smears miss.</li>\r\n<li><strong>Use case:</strong> Preferred when routine night-blood surveys show <strong>few or no mf</strong>, but infection is suspected.</li>\r\n<li><strong>Operational note:</strong> Requires <strong>collection and filtration of blood</strong> with subsequent microscopic examination of the <strong>filter surface</strong>.</li>\r\n<li><strong>Comparison with smears:</strong> Outperforms both <strong>thick</strong> and <strong>thin films</strong> for <strong>low parasite density</strong>.</li>\r\n<li><strong>Epidemiologic value:</strong> Helps in <strong>surveys</strong> where detection of <strong>low-level carriers</strong> matters for control programs.</li>\r\n<li><strong>Limitation (relative):</strong> Needs <strong>equipment/consumables</strong> and <strong>trained staff</strong>, but still yields <strong>highest sensitivity</strong> among routine field methods.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Thick film (Option A):</strong> Useful and commonly used for <strong>mass blood surveys</strong>, but <strong>less sensitive</strong> for <strong>low-density</strong> infections compared with membrane filtration.</p>\r\n<p><strong>Thin film (Option B):</strong> Good for <strong>species identification</strong> by morphology, yet <strong>least sensitive</strong> for detecting <strong>scanty mf</strong>.</p>\r\n<p><strong>DEC provocation test (Option D):</strong> <strong>Increases circulating mf</strong> after giving <strong>diethylcarbamazine</strong>, aiding detection, but it is <strong>not the most sensitive</strong> routine method and involves <strong>drug administration</strong>.</p>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">3 mg/kg/day</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">6 mg/kg/day</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">8 mg/kg/day</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">10 mg/kg/day</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The dose of diethylcarbamazine (DEC) for the treatment of Bancroftian filariasis is -</span></p>",
      "unique_key": "DT1231418",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231418,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The recommended dose of DEC for Bancroftian filariasis is <strong>6 mg/kg/day</strong>, which has been shown to be effective in clearing microfilariae from the blood and controlling the infection.</p>\r\n<ul>\r\n<li><strong>Diethylcarbamazine (DEC):</strong> An antifilarial drug effective against microfilariae and some adult worms.</li>\r\n<li><strong>Standard regimen:</strong> 6 mg/kg/day for 12 days (usually given in divided doses).</li>\r\n<li><strong>Mechanism:</strong> Rapidly absorbed and effective in killing microfilariae; its exact effect on adult worms is uncertain.</li>\r\n<li><strong>Toxic reactions:</strong> May occur due to the drug itself (e.g., headache, dizziness, nausea, vomiting) or due to the destruction of microfilariae (e.g., fever, lymphadenitis, local inflammation). These reactions are usually transient.</li>\r\n<li><strong>Caution:</strong> Should be given under supervision in endemic areas, as large-scale killing of microfilariae can cause systemic symptoms.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>3 mg/kg/day (Option A):</strong> Lower than the recommended dose; may result in incomplete clearance of infection.</p>\r\n<p><strong>8 mg/kg/day (Option C):</strong> Higher than the standard dose; increases risk of adverse reactions without additional benefit.</p>\r\n<p><strong>10 mg/kg/day (Option D):</strong> Significantly higher than recommended; may cause unnecessary toxicity.</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Dengvaxia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">DENvax</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetra-vax DV</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">V-180</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">WHO-approved dengue vaccine for individuals seropositive for the dengue virus is -</span></p>",
      "unique_key": "DT1231419",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231419,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Dengvaxia (CYD-TDV) by Sanofi Pasteur is the first and only WHO-approved dengue vaccine for use in individuals who are seropositive for dengue virus. It is a live attenuated tetravalent vaccine effective against dengue virus serotypes 1-4, approved for use in individuals aged 9-45 years or 9-60 years (depending on the license) residing in endemic areas.</p>\r\n<ul>\r\n<li><strong>Vaccine schedule:</strong> 3 doses of 0.5 mL at 6-month intervals.</li>\r\n<li><strong>Target group:</strong> Only seropositive individuals, as vaccination in seronegative persons may increase the risk of severe dengue on subsequent infection.</li>\r\n<li><strong>Mode of administration:</strong> Subcutaneous route.</li>\r\n<li><strong>Formulation:</strong> Supplied as a freeze-dried product to be reconstituted before use.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>DENvax (Option B):</strong> Vaccine candidate under development by Takeda; not yet WHO-approved for use in seropositive individuals.</p>\r\n<p><strong>Tetra-vax DV (Option C):</strong> No WHO-approved vaccine by this name; may refer to experimental formulations.</p>\r\n<p><strong>V-180 (Option D):</strong> Investigational dengue vaccine; not approved by WHO.</p>",
      "correct_choice_id": 51,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluids</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelets</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryoglobulins</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">FFP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The cornerstone of the treatment of a dengue patient with warning signs is -</span></p>",
      "unique_key": "DT1231421",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231421,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>IV fluid therapy is the mainstay of management in dengue patients with warning signs, as it corrects plasma leakage, restores intravascular volume, and prevents progression to shock. Early and appropriate fluid replacement improves outcomes and reduces mortality.</p>\r\n<ul>\r\n<li><strong>Rationale:</strong> Dengue with warning signs indicates increased risk of progression to severe disease due to plasma leakage. Maintaining adequate perfusion and preventing hypovolemic shock is the primary therapeutic goal, and IV crystalloids are the first-line intervention.</li>\r\n<li><strong>Fluid type and rate:</strong> Crystalloid solutions (e.g., normal saline, Ringer's lactate) are preferred. Rates are adjusted based on hematocrit changes and vital signs, with careful monitoring to prevent fluid overload.</li>\r\n<li><strong>Monitoring:</strong> Frequent clinical assessment of pulse, BP, urine output, and hematocrit is essential. Improvement is marked by a falling hematocrit with stable vital signs.</li>\r\n<li><strong>Adjuncts:</strong> Platelet transfusion is only indicated in specific situations, such as severe thrombocytopenia with bleeding; FFP is reserved for coagulopathy with bleeding.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Platelets (Option B):</strong> Used only for severe thrombocytopenia with bleeding; not first-line for patients with warning signs.</p>\r\n<p><strong>Cryoglobulins (Option C):</strong> Not part of dengue treatment; no role in acute management.</p>\r\n<p><strong>FFP (Option D):</strong> Reserved for coagulopathy with significant bleeding; not used routinely.</p>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">No episode of fever for more than 24 hours with paracetamol</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">After the return of appetite</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine output more than 200 ml</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">After 24 hours from recovery of shock</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">When can a patient with dengue hemorrhagic shock be discharged?</span></p>",
      "unique_key": "DT1231422",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231422,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The return of appetite is one of the essential discharge criteria for patients recovering from dengue hemorrhagic fever or shock. It signifies clinical improvement, adequate recovery from the acute illness, and readiness for home care, provided other discharge parameters are also met.</p>\r\n<p><strong>Criteria for discharge in dengue (as per WHO/standard guidelines):</strong></p>\r\n<ul>\r\n<li>Absence of fever for at least 24 hours without the use of antipyretic drugs</li>\r\n<li>Return of appetite</li>\r\n<li>Visible clinical improvement</li>\r\n<li>Good urine output</li>\r\n<li>At least 2-3 days after recovery from shock</li>\r\n<li>No respiratory distress from pleural effusion or ascites</li>\r\n<li>Platelet count &gt; 50,000/cu.mm</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>No episode of fever for more than 24 hours with paracetamol (Option A):</strong> Fever resolution is important, but it must occur without antipyretic support and in conjunction with other discharge criteria.</p>\r\n<p><strong>Urine output more than 200 ml (Option C):</strong> Adequate urine output is a sign of improved renal function, but it alone is insufficient for discharge without meeting all other clinical criteria.</p>\r\n<p><strong>After 24 hours from recovery of shock (Option D):</strong> Discharge is not based solely on time after recovery from shock; all WHO discharge criteria must be fulfilled.</p>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 50 mg for 3 days + Sulfadoxine-Pyrimethamine (500 mg & 25 mg) single dose + Primaquine for 14 days</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate alone 4 mg/kg if patient were pregnant and in second trimester</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 200 mg + Sulfadoxine-Pyrimethamine (750 mg & 37.5 mg) daily for 3 days</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate 4 mg/kg for 3 days + Sulfadoxine-Pyrimethamine (25 mg & 1.25 mg/kg) single dose + Primaquine 0.75 mg/kg single dose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was admitted to a government hospital with microscopically confirmed Plasmodium falciparum infection. Which one of the following treatments is indicated?</span></p>",
      "unique_key": "DT1231424",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231424,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The recommended treatment for uncomplicated P. falciparum malaria in government facilities follows the national drug policy. Artemisinin-based combination therapy (ACT) with artesunate and sulfadoxine-pyrimethamine (SP) is given, along with a single dose of primaquine to clear gametocytes and interrupt transmission.</p>\r\n<ul>\r\n<li><strong>Artesunate:</strong> 4 mg/kg body weight daily for 3 days.</li>\r\n<li><strong>SP:</strong> Single dose of 25 mg/kg sulfadoxine + 1.25 mg/kg pyrimethamine on the first day.</li>\r\n<li><strong>Primaquine:</strong> Single dose of 0.75 mg/kg on the second day (contraindicated in pregnancy and children &lt;1 year).</li>\r\n</ul>\r\n<p>This regimen ensures rapid parasite clearance, prevents recrudescence, and limits transmission in the community.</p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Artesunate 50 mg for 3 days + Sulfadoxine-Pyrimethamine (500 mg &amp; 25 mg) single dose + Primaquine for 14 days (Option A):</strong> Incorrect dosing of artesunate and unnecessary prolonged primaquine course; 14-day primaquine is indicated for P. vivax hypnozoite eradication, not P. falciparum.</p>\r\n<p><strong>Artesunate alone 4 mg/kg if patient were pregnant and in second trimester (Option B):</strong> Monotherapy is avoided due to risk of resistance; ACT remains preferred even in pregnancy (except first trimester where quinine is used).</p>\r\n<p><strong>Artesunate 200 mg + Sulfadoxine-Pyrimethamine (750 mg &amp; 37.5 mg) daily for 3 days (Option C):</strong> Incorrect SP dosing; SP is given as a single dose, not daily for 3 days.</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">0.8%</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">1.2%-1.8%</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">10%</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">100%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">MBER (Monthly Blood Examination Rate) norms laid down by NVBDCP for malaria fever surveillance during the transmission season is:</span></p>",
      "unique_key": "DT1231426",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231426,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The NVBDCP recommends maintaining an MBER between <strong>1.2%-1.8%</strong> during the malaria transmission season to ensure adequate surveillance coverage while being practical for field implementation.</p>\r\n<ul>\r\n<li><strong>Definition:</strong>\r\n<ul>\r\n<li>MBER = Percentage of population at risk for malaria whose blood samples are examined for malaria parasites each month.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Purpose:</strong>\r\n<ul>\r\n<li>To assess the effectiveness of malaria control programs.</li>\r\n<li>To ensure adequate fever surveillance during the transmission season.</li>\r\n</ul>\r\n</li>\r\n<li><strong>NVBDCP Norms:</strong>\r\n<ul>\r\n<li>For the malaria transmission season, the <strong>norm is 1.2%&ndash;1.8%</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Reason for Norm Selection:</strong>\r\n<ul>\r\n<li>Ensures adequate coverage for detecting malaria cases.</li>\r\n<li>Feasible for implementation in routine surveillance programs.</li>\r\n<li>Allows timely diagnosis and treatment to reduce malaria morbidity and mortality.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Importance of Maintaining Norms:</strong>\r\n<ul>\r\n<li>Helps track transmission trends.</li>\r\n<li>Facilitates early intervention measures.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Balance Between Coverage &amp; Feasibility:</strong>\r\n<ul>\r\n<li>Too low &rarr; risk of missing cases.</li>\r\n<li>Too high &rarr; impractical in field conditions.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>0.8% (Option A):</strong> Too low for effective malaria surveillance; insufficient coverage may cause delays in diagnosis and treatment.</p>\r\n<p><strong>10% (Option C):</strong> Impractically high; overly resource-intensive for regular implementation in endemic settings.</p>\r\n<p><strong>100% (Option D):</strong> Not feasible or required; testing the entire population monthly is unrealistic and unnecessary.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Rabies</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Leprosy</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">STDs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Remote sensing can be used as a tool for surveillance of which of the following diseases?</span></p>",
      "unique_key": "DT1231427",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231427,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Remote sensing is particularly useful in malaria surveillance as it provides environmental data, such as vegetation, rainfall, and temperature, that influence mosquito breeding and transmission patterns.</p>\r\n<ul>\r\n<li><strong>Definition:</strong>\r\n<ul>\r\n<li>Remote sensing = Collection of information about an area from a distance (satellites or aircraft).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Relevance in Public Health:</strong>\r\n<ul>\r\n<li>Helps identify environmental conditions linked to vector-borne disease transmission.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Application in Malaria:</strong>\r\n<ul>\r\n<li>Detects vegetation cover, water bodies, rainfall, and temperature variations.</li>\r\n<li>Assesses mosquito breeding habitats.</li>\r\n<li>Identifies high-risk areas for malaria transmission.</li>\r\n<li>Guides vector control interventions.</li>\r\n<li>Monitors changes in prevalence over time.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Malaria Fits Best:</strong>\r\n<ul>\r\n<li>Transmission closely tied to environmental and climatic factors measurable by remote sensing.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Rabies (Option A):</strong> Surveillance is based on monitoring animal cases and vaccination programs; remote sensing is not suited for direct rabies detection.</p>\r\n<p><strong>Leprosy (Option B):</strong> Mainstay is early case detection and contact tracing; remote sensing plays no primary role.</p>\r\n<p><strong>STDs (Option D):</strong> Surveillance relies on clinical/lab reporting; environmental mapping offers little direct benefit.</p>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Burrow's index</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Cheopis index</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific percentage of fleas</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Total flea index</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Severity of spreading of plague is detected by -</span></p>",
      "unique_key": "DT1231429",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The severity of plague spread, particularly in bubonic plague, is assessed using flea density indices. The <strong>Cheopis index</strong> measures the average number of Xenopsylla cheopis fleas per rat. A value &gt;1 is considered a potential indicator of an explosive plague situation.</p>\r\n<ul>\r\n<li><strong>Cheopis index</strong>:\r\n<ul>\r\n<li>Defined as the average number of X. cheopis per rat.</li>\r\n<li>It is a species flea index (specific to X. cheopis).</li>\r\n<li>Values <strong>&gt;1</strong> indicate potential plague outbreak risk.</li>\r\n<li>Used as a warning signal for plague surveillance.</li>\r\n<li>Helps quantify <strong>severity of infestation</strong> and transmission potential.</li>\r\n<li>Particularly relevant in <strong>bubonic plague</strong>, transmitted by fleas.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Other flea indices (for comparison):</strong>\r\n<ul>\r\n<li><strong>Total flea index</strong>: Average number of all flea species per rat.</li>\r\n<li><strong>Specific percentage of fleas</strong>: % of fleas that are of a specific species on rats.</li>\r\n<li><strong>Burrow index</strong>: Average number of free-living fleas per rodent burrow.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Significance:</strong>\r\n<ul>\r\n<li>Cheopis index focuses on the primary vector species (X. cheopis), making it a more precise indicator of the threat level compared to broader or less specific indices.</li>\r\n<li>A high Cheopis index signals <strong>intensified control measures</strong> to prevent an outbreak.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Burrow's index (Option A):</strong> Measures free-living fleas per burrow, reflects environmental contamination but not direct flea density on hosts.</p>\r\n<p><strong>Specific percentage of fleas (Option C):</strong> Shows proportion of a flea species but doesn&rsquo;t measure average density per host.</p>\r\n<p><strong>Total flea index (Option D):</strong> Measures all flea species per rat, less specific for X. cheopis-related transmission risk.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Burrow's index</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Cheopis index</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific percentage of fleas</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Total flea index</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following indicates the maximum explosiveness of the situation in plague?</span></p>",
      "unique_key": "DT1231431",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The maximum explosiveness of a plague situation refers to the severity and potential for rapid spread of the disease through flea transmission from rodent populations. <strong>The Cheopis index</strong> is the most appropriate indicator, as it quantifies flea density and directly reflects the intensity of infestation.</p>\r\n<ul>\r\n<li><strong>Cheopis index</strong>:\r\n<ul>\r\n<li>Measures the density of fleas by calculating the average number of Xenopsylla cheopis found on rodents.</li>\r\n<li>Higher values indicate greater flea density and higher transmission risk.</li>\r\n<li>Directly correlates with the severity of infestation and potential for rapid plague spread.</li>\r\n<li>Useful for identifying high-risk areas and prioritizing control measures.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Why Cheopis index reflects maximum explosiveness</strong>:\r\n<ul>\r\n<li>Targets the primary vector (X. cheopis) in plague transmission.</li>\r\n<li>Provides a quantitative and standardized measure for surveillance.</li>\r\n<li>Helps anticipate outbreak potential and initiate timely intervention.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Burrow's index (Option A):</strong> Measures the proportion of rodent burrows infested with fleas; reflects prevalence, not flea density.</p>\r\n<p><strong>Specific percentage of fleas (Option C):</strong> Gives the proportion of fleas in the environment; lacks standardization for infestation intensity.</p>\r\n<p><strong>Total flea index (Option D):</strong> Measures total fleas in an area; does not specifically indicate flea density within rodent populations.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Hard tick</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Soft tick</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Rat flea</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Louse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Plague is transmitted by -</span></p>",
      "unique_key": "DT1231432",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231432,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The primary vector for plague transmission is the <strong>rat flea</strong>, <strong>Xenopsylla cheopis</strong>. These fleas infest rodents, particularly rats, and acquire Yersinia pestis when feeding on infected rodents. Infected fleas can then transmit the bacterium to humans through bites.</p>\r\n<ul>\r\n<li><strong>Plague transmission dynamics:</strong>\r\n<ul>\r\n<li>Caused by Yersinia pestis, a zoonotic disease mainly involving rodents and fleas.</li>\r\n<li>Rat flea (Xenopsylla cheopis) is the most efficient and common vector.</li>\r\n<li>Flea bite inoculates plague bacilli into the human bloodstream during feeding.</li>\r\n<li>Fleas become infected after feeding on infected rodents and retain the pathogen in their foregut, which is regurgitated into the bite wound.</li>\r\n<li>Environmental factors such as rodent abundance and flea activity play a significant role in maintaining the transmission cycle.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Hard tick (Option A):</strong> Not a vector for plague; mainly transmits Lyme disease and Rocky Mountain spotted fever.</p>\r\n<p><strong>Soft tick (Option B):</strong> Associated with tick-borne relapsing fever; not a primary vector for plague.</p>\r\n<p><strong>Louse (Option D):</strong> Transmits diseases like epidemic typhus (Rickettsia prowazekii) and trench fever; not involved in plague transmission.</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Burrow's index</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Cheopis index</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Specific percentage of fleas</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Total flea index</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">______________ is the average number of free-living fleas per species per rodent burrow.</span></p>",
      "unique_key": "DT1231434",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231434,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Burrow's index refers to the <strong>average number of free-living fleas per species per rodent burrow</strong>. This index is an important entomological measure used to assess flea density in rodent habitats and helps evaluate the risk of plague transmission. Higher burrow index values indicate a greater flea population in the environment, signifying the need for vector control measures.</p>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Cheopis index (Option B):</strong> Indicates the average number of Xenopsylla cheopis per rat. It is species-specific and widely used in plague surveillance.</p>\r\n<p><strong>Specific percentage of fleas (Option C):</strong> Refers to the percentage of a particular flea species among the total fleas collected from rodents.</p>\r\n<p><strong>Total flea index (Option D):</strong> Denotes the total number of all flea species per rat, not specific to free-living fleas in burrows.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Obligate host</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Definitive host</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Intermediate host</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Transport host</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A host in which the parasite only passes through its sexual stage of maturity is called:</span></p>",
      "unique_key": "DT1231496",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231496,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>A <strong>definitive host</strong> is one in which the parasite reaches sexual maturity and reproduces sexually, completing its life cycle.</p>\r\n<ul>\r\n<li>This stage is essential for producing offspring or infective stages that can be transmitted to other hosts.</li>\r\n<li>In the given scenario, where the parasite passes only through its sexual stage of maturity, the definitive host is the correct term.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Obligate host (Option A):</strong> Refers to a host that is necessary for the completion of the parasite&rsquo;s life cycle, but does not specifically indicate where the sexual stage occurs.</p>\r\n<p><strong>Intermediate host (Option C):</strong> The host in which the parasite undergoes asexual reproduction or development but does not reach sexual maturity.</p>\r\n<p><strong>Transport host (Option D):</strong> A temporary host that harbors the parasite without further development, aiding its transmission to the definitive host.</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Anthropozoonoses</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Zooanthroponoses</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Amphixenosis</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Epornithic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A disease which is maintained in both humans and lower vertebrates and can be transmitted in either direction is called ________</span></p>",
      "unique_key": "DT1231497",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231497,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The correct answer is Amphixenosis because these diseases are maintained in both humans and lower vertebrates, and transmission can occur in either direction, from humans to animals or from animals to humans.</p>\r\n<ul>\r\n<li>Maintained in both humans and lower vertebrates.</li>\r\n<li>Transmission is bidirectional.</li>\r\n<li>Examples: Trypanosoma cruzi infection, Schistosoma japonicum infection.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Anthropozoonoses (Option A):</strong> Diseases primarily maintained in vertebrate animals and transmitted to humans; reverse transmission to animals is not common. Example: Rabies, plague.</p>\r\n<p><strong>Zooanthroponoses (Option B):</strong> Diseases primarily maintained in humans and transmitted to vertebrate animals; reverse transmission is rare. Example: Human tuberculosis transmitted to cattle.</p>\r\n<p><strong>Epornithic (Option D):</strong> Refers to an epidemic disease occurring in a bird population; not related to bidirectional transmission between humans and other vertebrates.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Filariasis</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Guinea worm</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Leprosy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Transmission Assessment Survey (TAS) is done in the following:</span></p>",
      "unique_key": "DT1231583",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231583,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The correct answer is <strong>Filariasis</strong> because <strong>Transmission Assessment Survey (TAS)</strong> is a <strong>WHO-recommended tool</strong> used to determine whether the <strong>transmission of lymphatic filariasis</strong> has been <strong>interrupted</strong> in an area after completion of several rounds of <strong>Mass Drug Administration (MDA)</strong>. TAS provides scientific evidence for deciding whether to <strong>stop MDA</strong> in that implementation unit.</p>\r\n<p><strong>Transmission Assessment Survey (TAS):</strong></p>\r\n<ul>\r\n<li>Conducted <strong>after 5-6 annual MDA rounds</strong> with high coverage.</li>\r\n<li>Helps decide whether MDA can be <strong>stopped</strong> in the surveyed area.</li>\r\n<li>Uses <strong>immunochromatographic test (ICT)</strong> or <strong>filariasis test strip (FTS)</strong> to detect <strong>circulating filarial antigen (CFA)</strong>.</li>\r\n<li>Targets <strong>6-7 year-old children</strong>, as they best reflect <strong>recent transmission</strong>.</li>\r\n<li>If prevalence is <strong>below threshold</strong>, the area moves to <strong>post-MDA surveillance phase</strong>.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Malaria (Option A):</strong> A mosquito-borne disease caused by <strong>Plasmodium species</strong>. Surveillance methods include <strong>parasite prevalence surveys</strong>, <strong>vector monitoring</strong>, and <strong>rapid diagnostic tests</strong>, but <strong>TAS is not used</strong> in malaria control programs.</p>\r\n<p><strong>Guinea worm (Option C):</strong> A waterborne parasitic infection caused by <strong>Dracunculus medinensis</strong>. Eradication is achieved through <strong>case detection</strong>, <strong>containment measures</strong>, and <strong>safe water provision</strong>. <strong>TAS is not part</strong> of Guinea worm surveillance.</p>\r\n<p><strong>Leprosy (Option D):</strong> A chronic infectious disease caused by <strong>Mycobacterium leprae</strong>. Control relies on <strong>early detection</strong>, <strong>multidrug therapy (MDT)</strong>, and <strong>contact tracing</strong>. <strong>TAS is not used</strong> in leprosy programs.</p>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Artesunate + Sulfadoxine + Pyrimethamine + Primaquine</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Artemether + Lumefantrine + Primaquine</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine + Primaquine</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Artemether + Sulfadoxine + Pyrimethamine + Primaquine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A person returning from Assam is diagnosed with Plasmodium falciparum malaria. Which of the following drug combinations is used for treatment?</span></p>",
      "unique_key": "DT1231593",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231593,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The correct treatment for Plasmodium falciparum malaria in <strong>North-Eastern states</strong> (including Assam) is <strong>Artemether + Lumefantrine (ACT-AL)</strong> for 3 days, along with <strong>Primaquine 0.75 mg/kg body weight on day 2</strong>. This is per the <strong>national drug policy for malaria</strong> to address <strong>chloroquine resistance</strong> and reduce <strong>gametocyte transmission</strong>.</p>\r\n<ul>\r\n<li>In <strong>North-Eastern states</strong>, P. falciparum cases are treated with <strong>ACT-AL (Artemether 20 mg + Lumefantrine 120 mg)</strong> for 3 days.</li>\r\n<li><strong>Primaquine</strong> (single dose, 0.75 mg/kg body weight) is given on <strong>day 2</strong> to clear gametocytes and prevent further transmission.</li>\r\n<li><strong>ACT-AL</strong> is preferred here due to high levels of resistance to other regimens like ACT-SP and chloroquine.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Malaria (Option A):</strong> <strong>Artesunate + Sulfadoxine + Pyrimethamine + Primaquine</strong> is recommended for P. falciparum cases in <strong>other states</strong> (non-NE states), not for North-Eastern states, due to <strong>SP resistance</strong> in the NE region.</p>\r\n<p><strong>Malaria (Option C):</strong> <strong>Chloroquine + Primaquine</strong> is used for P. vivax malaria in chloroquine-sensitive areas. It is <strong>not used</strong> for P. falciparum in NE states because of <strong>widespread chloroquine resistance</strong>.</p>\r\n<p><strong>Malaria (Option D):</strong> <strong>Artemether + Sulfadoxine + Pyrimethamine + Primaquine</strong> is not a recommended combination in any standard guideline for NE states. The NE policy strictly recommends <strong>ACT-AL</strong> with primaquine.</p>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Anopheles stephensi</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Aedes aegypti</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Culex pipiens</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Phlebotomus papatasi</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Vector for Zika virus is:</span></p>",
      "unique_key": "DT1231618",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231618,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The <strong>Zika virus</strong> is transmitted to humans by the bite of infected <strong>Aedes mosquitoes</strong>, mainly <strong>Aedes aegypti</strong>, and to a lesser extent <strong>Aedes albopictus</strong>. These mosquitoes are also responsible for the transmission of other arboviruses such as <strong>dengue</strong>, <strong>chikungunya</strong>, and <strong>yellow fever</strong>. The <strong>Aedes aegypti</strong> mosquito is well adapted to urban habitats, breeding in small collections of standing water, and is a highly efficient vector for Zika virus transmission.</p>\r\n<ul>\r\n<li><strong>Agent factor:</strong> Zika virus is a <strong>mosquito-borne flavivirus</strong>.</li>\r\n<li><strong>Mode of transmission:</strong> Mainly by <strong>Aedes aegypti</strong>; occasionally by <strong>Aedes albopictus</strong>.</li>\r\n<li><strong>Epidemiology:</strong> Widely prevalent in tropical and subtropical regions.</li>\r\n<li><strong>Vector control:</strong> Focuses on reducing mosquito breeding sites and preventing bites.</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Anopheles stephensi (Option A):</strong> Vector for <strong>malaria</strong>, especially in urban areas; not involved in Zika virus transmission.</p>\r\n<p><strong>Culex pipiens (Option C):</strong> Known for transmitting <strong>West Nile virus</strong> and <strong>filariasis</strong>; does not transmit Zika virus.</p>\r\n<p><strong>Phlebotomus papatasi (Option D):</strong> Vector for <strong>cutaneous leishmaniasis</strong>; not associated with Zika virus.</p>",
      "correct_choice_id": 192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Amphotericin B</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Bedaquiline</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Tigecycline</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluconazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male presents with fever for 3 weeks, not responding to antibiotics and antimalarials. Abdominal distension is noted. rk39 dipstick test is positive. What is the most appropriate management?</span></p>",
      "unique_key": "DT1231689",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231689,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The patient's <strong>prolonged fever</strong>, <strong>abdominal distension</strong> due to splenomegaly, and <strong>positive rk39 dipstick test</strong> are highly suggestive of <strong>visceral leishmaniasis (Kala-azar)</strong>.</p>\r\n<ul>\r\n<li>According to the <strong>National Kala-azar Elimination Programme guidelines</strong>, <strong>Liposomal Amphotericin B</strong> is the preferred first-line treatment due to its high efficacy, safety, and patient compliance.</li>\r\n<li><strong>Causative agent:</strong> Leishmania donovani</li>\r\n<li><strong>Vector:</strong> Phlebotomus argentipes (sandfly)</li>\r\n<li><strong>Transmission:</strong> Bite of infected female sandfly</li>\r\n<li><strong>Diagnosis:</strong> rk39 rapid diagnostic test detects antibodies against Leishmania</li>\r\n<li><strong>First-line treatment:</strong> Liposomal Amphotericin B (single dose 10 mg/kg body weight IV infusion)</li>\r\n<li><strong>Alternative regimens:</strong> Combination therapy (Miltefosine + Paromomycin), Amphotericin B deoxycholate (multiple doses)</li>\r\n<li><strong>Public health approach:</strong> Early detection, complete treatment, vector control</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Bedaquiline (Option B):</strong> Used in the treatment of multidrug-resistant tuberculosis; no role in visceral leishmaniasis.</p>\r\n<p><strong>Tigecycline (Option C):</strong> A broad-spectrum glycylcycline antibiotic for bacterial infections; ineffective against Leishmania.</p>\r\n<p><strong>Fluconazole (Option D):</strong> An antifungal drug for Candida and Cryptococcus infections; no antileishmanial activity.</p>",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">RBS < 40 mg%</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Unarousable coma</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">S. Creatinine 5.2 mg/dL</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Arterial pH > 7.4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old male presents with fever with chills and rigor for 6 days and altered mental status for 1 day. Rapid Diagnostic Test (RDT) for Plasmodium falciparum is positive. Which of the following is not a complication of this condition?</span></p>",
      "unique_key": "DT1231690",
      "question_audio": null,
      "question_video": null,
      "map_id": 1231690,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>This patient&rsquo;s presentation is consistent with <strong>severe malaria</strong> due to Plasmodium falciparum, confirmed by a positive RDT. Severe malaria is associated with multiple organ dysfunction and metabolic derangements.</p>\r\n<ul>\r\n<li><strong>In severe malaria</strong>, <strong>metabolic acidosis</strong> is common due to tissue hypoperfusion, lactic acid build-up, and impaired oxygen utilization.</li>\r\n<li>This results in <strong>arterial pH &lt; 7.4</strong>.</li>\r\n<li>An <strong>arterial pH &gt; 7.4</strong> does not occur as a complication; in fact, it would indicate alkalosis, which is not typical in severe malaria.</li>\r\n</ul>\r\n<p><strong>Complications of Severe Malaria:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025092508f00b5f-627a-46a7-aae1-79fdd3b98e8b.png\">\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Malaria (Option A):</strong> Hypoglycemia is a recognized complication of severe malaria, particularly with quinine use or in children.</p>\r\n<p><strong>Malaria (Option B):</strong> Unarousable coma indicates cerebral malaria, a hallmark of severe P. falciparum infection.</p>\r\n<p><strong><strong>Malaria (Option C):</strong> S. Creatinine 5.2 mg/dL reflects acute kidney injury, a known severe malaria complication.</strong></p>",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}